Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
K NitschkeP ErbenF WaldbilligA AbdelhadiC-A WeisM GottschaltS WahbyP NuhnM BoutrosM S MichelJ von HardenbergThomas Stefan WorstPublished in: World journal of urology (2019)
FABP5 overexpression is frequent in PCa, but seems to be restricted to TMPRESS2:ERG fusion-negative tumors and is associated with SPOP and FOXA1 mutations. FABP5 overexpression appears to be indicative for increased activity in PPAR signaling, which is potentially druggable.